Sign in
Български
Čeština
Dansk
Deutsch
Eesti
Ελληνικά
Español
Français
Hrvatski
Italiano
Latviešu
Lietuvių
Magyar
Nederlands
Norsk
Polski
Português
Română
Slovenčina
Slovenščina
Српски (Ћирилица)
Suomi
Svenska
Türkçe
Русский
Українська
Regulatory news
May 2026
Addition of New Substances to the List of Drug Precursors
The European Commission has adopted the new Delegated Regulation (EU) 2026/314, which expands the list of controlled drug precursors under Regulations (EC) No 273/2004 and (EC) No 111/2005. Stricter controls will now apply in particular to substances used in the production of the synthetic cathinones 3-CMC, 3-MMC, 4-CMC and 4-MMC (mephedrone), as well as phenyl-2-nitropropene used in the manufacture of amphetamine.
April 2026
Amendment to Annex XVII of the REACH Regulation
This regulation amends Annex XVII of REACH by introducing restrictions on 2,4-dinitrotoluene in articles and sets conditions for its placing on the market and use, including a transitional period for compliance.
March 2026
Basic copper carbonate in biocidal products of type 8
Commission Implementing Decision (EU) 2026/576 under the Biocidal Products Regulation (EU No 528/2012) postpones the expiry date of the approval of the active substance basic copper carbonate for biocidal products of type 8 until 31 July 2029 due to the ongoing review of its renewal.
HPT in biocidal products of type 6
Commission Implementing Decision (EU) 2026/599 under the Biocidal Products Regulation (EU No 528/2012) does not approve the active substance formaldehyde released from the reaction products of paraformaldehyde and 2-hydroxypropylamine for biocidal products of type 6 due to failure to meet safety criteria (carcinogenicity category 1B).
Copper oxide in biocidal products of type 8
Commission Implementing Decision (EU) 2026/619 under the Biocidal Products Regulation (EU No 528/2012) postpones the expiry date of the approval of the active substance copper oxide for biocidal products of type 8 until 31 July 2029 due to the ongoing review of its renewal.
Alpha-chloralose in biocidal products of type 14
Commission Implementing Decision (EU) 2026/578 under the Biocidal Products Regulation (EU No 528/2012) postpones the expiry date of the approval of the active substance alpha-chloralose for biocidal products of type 14 until 31 December 2027 due to the ongoing review of its renewal.
Copper hydroxide in biocidal products of type 8
Commission Implementing Decision (EU) 2026/579 extends, under the Biocidal Products Regulation (EU No 528/2012), the validity of the approval of the active substance copper hydroxide for biocidal products of type 8 until 31 July 2029 due to the ongoing review of its renewal.
DBNPA in biocidal products of type 11
Commission Implementing Regulation (EU) 2026/577 under the Biocidal Products Regulation (EU No 528/2012) approves the active substance 2,2-dibromo-2-cyanoacetamide (DBNPA) for use in biocidal products of type 11, thereby confirming compliance with safety requirements and allowing its legal use on the EU market.
New Detergents Regulation
Regulation (EU) 2026/405 introduces a new framework for detergents and surfactants, replacing the 2004 Regulation and modernising the rules with the aim of enhancing the protection of human health and the environment and harmonising requirements across the EU market.
New active substance for biocidal products
Commission Implementing Regulation (EU) 2026/385 under the Biocidal Products Regulation (EU No 528/2012) addresses the (non-)approval of the active substance formaldehyde released from the reaction products of paraformaldehyde and 2-hydroxypropylamine (3:2) for biocidal products with regard to exclusion criteria (carcinogenicity) and the assessment of the availability of alternatives and risks.
New active substance for biocidal products
Commission Regulation (EU) 2026/373 under the Biocidal Products Regulation (EU No 528/2012) approves the active substance formaldehyde released from the reaction products of paraformaldehyde and 2-hydroxypropylamine (1:1) for biocidal products of types 2, 11 and 13, exceptionally despite its classification as a category 1B carcinogen due to the absence of suitable alternatives.
January 2026
Postponement of the entry into force of the revised CLP Regulation
Regulation (EU) 2025/2439 amends CLP by postponing the applicability of new requirements for the classification, labelling and packaging of chemical substances introduced by Regulation (EU) 2024/2865 in order to provide companies with more time to prepare and reduce administrative burden.
© 2026 SBLCore
